RxDoctor Payments Data

Jessica Hunn, MD

Gynecologic Oncology · Salt Lake City, UTNPI 1992978712

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (46.6%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 99.8% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2022 at $205,455 and has fallen 75.1% since, to $51,131 in 2025.

$613,829in general payments, 2019–2025

Across 727 payments — averaging $844.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$613K
  • Hologic Sales And Service, LLC$377
  • Coopersurgical, Inc.$302
  • Baxter Healthcare$262
  • Conmed Corporation$120

What the payments were for

  • Speaking & faculty fees$261,81343%
  • Travel & lodging$31,9355%
  • Food & beverage$33,5795%
  • Education$286,25047%
  • Gifts$2520%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few gynecologic oncology providers in Utahto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$182,077
Medicare patients
246
Services billed
615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Megestrol Acetate50$4,459
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen112$588
Ibuprofen116$539
Tranexamic Acid14$253

Paid to pharmacies, not to this prescriber.

Other gynecologic oncology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →